ADVISORY, July 02, 2015 (GLOBE NEWSWIRE) --
Natera Inc. (Nasdaq:NTRA), a leading genetic testing company that develops and commercializes non-invasive methods for analyzing DNA, will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO) which will occur today, July 2.
In honor of the occasion, Matthew Rabinowitz, Chief Executive Officer will ring the Opening Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Thursday, July 2, 2015 – 9:15 a.m. to 9:30 a.m. ET
Natera Inc. Media Contact:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.
For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq
For news tweets, please visit our Twitter page at: http://twitter.com/nasdaq
For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/
A webcast of the Nasdaq Opening Bell will be available at:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Natera Inc. (Nasdaq:NTRA):
Natera is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The mission of the company is to help families diagnose and manage genetic disease. In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, CA, and currently offers a host of proprietary genetic testing services primarily to OB/GYN physicians and fertility centers. Tests include pre-implantation genetic screening and diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos during in vitro fertilization (IVF); miscarriage testing to rapidly analyze fetal chromosomes to understand the cause of a pregnancy loss; carrier screening tests to detect whether parents carry genetic variations that may result in disease in their child; and Panorama™, a safe, simple test for pregnant women that screens for the most common chromosomal anomalies in a fetus as early as nine weeks of gestation.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately $9.5 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.